Literature DB >> 19028119

Proteomic profiling in early venous stenosis formation in a porcine model of hemodialysis graft.

Sanjay Misra1, Alex A Fu, Alessandra Puggioni, James F Glockner, Michael A McKusick, Haraldur Bjarnason, Debabrata Mukhopadhyay.   

Abstract

PURPOSE: To use proteomic analysis to identify up- and downregulated proteins in early venous stenosis formation in a porcine model of hemodialysis graft failure.
MATERIALS AND METHODS: Pigs had chronic renal insufficiency created by subtotal renal infarction caused by renal artery embolization. Arteriovenous polytetrafluoroethylene grafts were placed 28 days later and the animals were killed after a further 3 days (n = 4), 7 days (n = 4), or 14 days (n = 4). Proteomic analysis with isotope-coded affinity tags and multidimensional liquid chromatography followed by tandem mass spectrometry was performed on the venous stenosis and control vessels. Expression of proteins was further confirmed by Western blot analysis. The blood urea nitrogen (BUN) and creatinine levels were determined before renal artery embolization and at the time of graft placement.
RESULTS: At graft placement, mean BUN and creatinine levels were significantly higher than before embolization (P < .05). Six proteins were identified that were common to all four animals at the same time point. Five proteins (alpha-fetoprotein, fetuin A, macrophage migration inhibitory factor, pyruvate dehydrogenase E1 component, and lactoferrin) were upregulated and one protein (decorin) was downregulated. Expression of macrophage migration inhibitory factor, alpha-fetoprotein, and lactoferrin was further validated with Western blotting. By day 14, lactoferrin and fetuin-A expression were increased significantly in early venous stenosis formation.
CONCLUSIONS: Significantly increased expression of lactoferrin and fetuin-A were observed in early venous stenosis by day 14. Understanding the role of lactoferrin and fetuin-A in hemodialysis vascular access failure could help in improving outcomes in patients undergoing hemodialysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028119      PMCID: PMC2679092          DOI: 10.1016/j.jvir.2008.10.004

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  41 in total

1.  Vascular access for hemodialysis.

Authors:  S J Schwab; J T Harrington; A Singh; R Roher; S A Shohaib; R D Perrone; K Meyer; D Beasley
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

2.  Demonstration of a new protein fraction in serum from the human fetus.

Authors:  C G BERGSTRAND; B CZAR
Journal:  Scand J Clin Lab Invest       Date:  1956       Impact factor: 1.713

3.  DNA microarray study on gene expression profiles in co-cultured endothelial and smooth muscle cells in response to 4- and 24-h shear stress.

Authors:  Sepideh Heydarkhan-Hagvall; Shu Chien; Sven Nelander; Yi-Chen Li; Suli Yuan; Jianmin Lao; Jason H Haga; Ian Lian; Phu Nguyen; Bo Risberg; Yi-Shuan Li
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

4.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags.

Authors:  S P Gygi; B Rist; S A Gerber; F Turecek; M H Gelb; R Aebersold
Journal:  Nat Biotechnol       Date:  1999-10       Impact factor: 54.908

5.  Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF).

Authors:  Anke Burger-Kentischer; Heike Göbel; Robert Kleemann; Alma Zernecke; Richard Bucala; Lin Leng; Doris Finkelmeier; Georg Geiger; Hans E Schaefer; Andreas Schober; Christian Weber; Herwig Brunner; Hartmut Rütten; Christian Ihling; Jürgen Bernhagen
Journal:  Atherosclerosis       Date:  2006-01       Impact factor: 5.162

Review 6.  Pyruvate dehydrogenase E1 alpha deficiency: males and females differ yet again.

Authors:  H H Dahl
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

7.  Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis.

Authors:  S N Giri; D M Hyde; R K Braun; W Gaarde; J R Harper; M D Pierschbacher
Journal:  Biochem Pharmacol       Date:  1997-12-01       Impact factor: 5.858

8.  Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts.

Authors:  Sanjay Misra; Michael G Doherty; David Woodrum; Jay Homburger; Jaywant N Mandrekar; Stephane Elkouri; Enrique A Sabater; Haraldur Bjarnason; Alex A Fu; James F Glockner; Eddie L Greene; Debabrata Mukhopadhyay
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

9.  Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries.

Authors:  R Riessen; J M Isner; E Blessing; C Loushin; S Nikol; T N Wight
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

10.  Cell proliferation in human arteriovenous fistulas used for hemodialysis.

Authors:  M Rekhter; S Nicholls; M Ferguson; D Gordon
Journal:  Arterioscler Thromb       Date:  1993-04
View more
  6 in total

1.  Differential gene expression patterns in vein regions susceptible versus resistant to neointimal hyperplasia.

Authors:  Sun Hyung Kwon; Li Li; Christi M Terry; Yan-Ting Shiu; Philip J Moos; Brett A Milash; Alfred K Cheung; Donald K Blumenthal
Journal:  Physiol Genomics       Date:  2018-05-11       Impact factor: 3.107

Review 2.  New Insights into Dialysis Vascular Access: Molecular Targets in Arteriovenous Fistula and Arteriovenous Graft Failure and Their Potential to Improve Vascular Access Outcomes.

Authors:  Timmy Lee; Sanjay Misra
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

3.  Evolution of shear stress, protein expression, and vessel area in an animal model of arterial dilatation in hemodialysis grafts.

Authors:  Sanjay Misra; Alex A Fu; Khamal D Misra; James F Glockner; Debabrata Mukhopadyay
Journal:  J Vasc Interv Radiol       Date:  2010-01       Impact factor: 3.464

4.  Rationale and Trial Design of MesEnchymal Stem Cell Trial in Preventing Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula (MEST AVF Trial).

Authors:  Ameet K Piryani; Sreenivasulu Kilari; Edwin Takahashi; Randall R DeMartino; Jay Mandrekar; Allan B Dietz; Sanjay Misra
Journal:  Kidney360       Date:  2021-09-28

Review 5.  Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis.

Authors:  Timmy Lee; Prabir Roy-Chaudhury
Journal:  Adv Chronic Kidney Dis       Date:  2009-09       Impact factor: 3.620

Review 6.  Role of Hypoxia and Metabolism in the Development of Neointimal Hyperplasia in Arteriovenous Fistulas.

Authors:  Nirvana Sadaghianloo; Julie Contenti; Alan Dardik; Nathalie M Mazure
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.